Very-Late-Onset Neuromyelitis Optica Spectrum Disorder in a Patient with Breast Cancer and Parkinson Disease.
Anti-aquaporin-4 antibody
Breast cancer
Neuromyelitis optica spectrum disorder
Parkinson disease
Journal
Case reports in neurology
ISSN: 1662-680X
Titre abrégé: Case Rep Neurol
Pays: Switzerland
ID NLM: 101517693
Informations de publication
Date de publication:
Historique:
received:
10
06
2020
accepted:
30
06
2020
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
13
3
2021
Statut:
epublish
Résumé
Anti-aquaporin-4 (anti-AQP-4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disorder resulting in severe, recurrent optic neuritis, transverse myelitis, brain stem syndrome, and other types of neurological involvement. Its median age of onset has been reported to be around 40 years. We report herein a case of very-late-onset NMOSD (76 years of age) and try to promote its awareness as a type of neurological deterioration in elder patients. A 76-year-old woman suffering from Parkinson disease was admitted to our hospital because of consciousness disturbance. Cranial magnetic resonance imaging revealed the presence of fluid-attenuated inversion recovery high-signal-intensity lesions in the right peri- and intralateral ventricle. Part of this lesion and the meninges showed gadolinium enhancement. Physical examination revealed the presence of a tumor in the right breast, which was later diagnosed as invasive ductal carcinoma. In addition, laboratory examinations led to the detection of anti-AQP-4 antibodies in her serum; consequently, the patient was diagnosed as having NMOSD. She received initial pulsed steroid therapy, followed by right mastectomy. Although the patient's consciousness improved significantly, she developed abrupt-onset bilateral leg weakness and multiple longitudinal spinal cord lesions. Additional steroid therapy ameliorated the patient's leg weakness and reduced the swelling of the spinal cord.
Identifiants
pubmed: 33708094
doi: 10.1159/000509859
pii: crn-0013-0053
pmc: PMC7923708
doi:
Types de publication
Case Reports
Langues
eng
Pagination
53-58Informations de copyright
Copyright © 2021 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors have no conflict of interest to declare.
Références
Curr Opin Neurol. 2012 Dec;25(6):795-801
pubmed: 23041955
eNeurologicalSci. 2018 Nov 19;13:35-37
pubmed: 30519648
J Neurol. 2020 May;267(5):1260-1268
pubmed: 31932911
Neurology. 2015 Jul 14;85(2):177-89
pubmed: 26092914
Mult Scler. 2018 Apr;24(5):685-688
pubmed: 28814166
J Neurol. 2015 May;262(5):1379-84
pubmed: 25957640
Neurol Neuroimmunol Neuroinflamm. 2019 Aug 30;6(6):
pubmed: 31471461
Neurol Ther. 2019 Dec;8(2):477-482
pubmed: 31267407
Neurology. 2015 Mar 17;84(11):1165-73
pubmed: 25695963
Mayo Clin Proc. 2017 Apr;92(4):663-679
pubmed: 28385199